Skip to main content
profile image
Selected Works of Carlo B. Bifulco, M.D.
Article
T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).
Journal of Clinical Oncology (2017)
  • Bernard A. Fox, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Brian C. Boulmay, Louisiana State University
  • Rui Li, Providence Cancer Center, Portland, OR;
  • Kyle T Happel, LSU Health Sciences Center New Orleans
  • Christopher Paustian, UbiVac, Portland, OR;
  • Tarsem Lal Moudgil, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Sachin Puri, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Christopher Dubay, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Yoshinobu Koguchi, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Adi Mehta, Oslo University Hospital
  • Fridtjof Lund-Johansen, Oslo University Hospital
  • Brenda K Fisher, Providence Cancer Center, Portland, OR;
  • William L Redmond, Earl A. Chiles Research Institute, Portland, OR;
  • Carlo Bruno Bifulco, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Augusto Ochoa, LSU Health Sciences Center New Orleans
  • Hong-Ming Hu, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Traci Hilton, UbiVac, Portland, OR;
  • Walter John Urba, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
  • Rachel E. Sanborn, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR;
Link
Disciplines
Publication Date
May 30, 2017
DOI
10.1200/JCO.2017.35.15_SUPPL.E14639
Citation Information
Bernard A. Fox, Brian C. Boulmay, Rui Li, Kyle T Happel, et al.. "T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts)." Journal of Clinical Oncology Vol. 35 (2017)
Available at: http://works.bepress.com/carlo-bifulco/76/